San Francisco, California, May 30, 2017: The market for muscle wasting disorder is expected be fueled by the sedentary lifestyle of consumers in developed regions, states TMR Research in a research report. The market research report is titled, “Muscle Wasting Disorder Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025.”
Owing to the prosperity and development regions such as Europe and North America, the number of sedentary jobs has significantly risen in the last couple of years. This has further led to a rise in spinal and muscular disorders, one of them being muscle wasting disorder. The growing urban population submitting to posture and muscle related disorders in developing as well as developed regions is expected to be a key growth driver of the global muscle wasting disorder market. The growing pervasiveness of the Western deskbound lifestyle in countries in Asia Pacific is expected to open growth opportunities for the market in Asia Pacific over the coming years. The rising old age population in the Asia Pacific region is further expected to have a major positive impact in the growth of the market in the region.
The growing health awareness among consumers on the other hand could be an important restraining factor for the growth of the global muscle wasting disorders market in the upcoming years. Inhabitants of developed regions are now starting to recognize the glitches caused by a chiefly inactive lifestyle, and the call for a healthier diet along with regular exercise is hence growing. The stable advancement in the investigative technologies used for detecting muscle wasting disorders are also likely to have a noteworthy positive influence on the muscle wasting disorder market in the near future.
The propensity of the body to drop tissue is denoted as muscle wasting disorder, or mainly muscle atrophy. Muscle wasting disorder can be categorized as disuse atrophy or neurogenic atrophy. Disuse atrophy is instigated by the dearth of physical activity, while neurogenic atrophy happens owing to a wound or disease of a nerve that joins the muscle. Whereas the occurrence of disuse atrophy is intensifying due to the mounting trend of deskbound jobs and swelling number of individuals with firm medical conditions that confines their activities, neurogenic atrophy is more austere and is fairly prevalent too.
Region-wise, the market is expected to be led by North America owing to the widespread of sedentary jobs across the region. The players in the global muscle wasting disorder market are Paratek Pharmaceuticals, Inc., Cellular Biomedicine Group, Inc., Nexgenix Pharmaceuticals, LLC, California Stem Cell, Inc., Neurotune AG, Isis Pharmaceuticals, Inc., Pfizer, Inc., and Genzyme Corporation.